[ad_1] Vaccination rates have been rising steadily in recent weeks as fears of the delta variant increase. Providers were managing Nearly 837,000 shots were fired per day last weekend, andRead More
Tag: FDA
Stocks rise broadly; Pfizer wins after FDA approves vaccine
[ad_1] Stocks rose solidly on Wall Street in Monday afternoon trading, prompting the S&P 500 to recoup last week’s losses and eclipse its all-time high. The benchmark index rose 1%Read More
FDA Approves GHB, a ‘History Rape’ Drug for Rare Sleep Disorder
[ad_1] On the black market, homemade GHB, also known as liquid ecstasy, goop, and G, can be purchased by the clamshell. $5 to $25. But Xyrem and Xywav’s night treatmentsRead More
FDA Targets Vaccine Booster Rate for Patients with Immunodeficiency
[ad_1] The Food and Drug Administration is stepping up efforts to allow extra doses of coronavirus vaccines for Americans with weakened immune systems; This is a change that reflects growingRead More
FDA Aims to Speed Up Extra Doses of Vaccines for Patients with Immunodeficiency
[ad_1] The Food and Drug Administration is stepping up efforts to allow extra doses of coronavirus vaccines for Americans with weakened immune systems; This is a change that reflects growingRead More
FDA Targets Early Approval of Pfizer Vaccine
[ad_1] WASHINGTON — With a new surge of Covid-19 infections plaguing much of the United States, the Food and Drug Administration has stepped up the timeline to fully approve Pfizer-BioNTech’sRead More
FDA Issues Rare Nerve Syndrome Warning to Johnson & Johnson
[ad_1] The database shows only one possible death of a Johnson & Johnson recipient vaccinated from Guillain-Barré syndrome. But the 57-year-old Delaware man has also suffered a heart attack andRead More
FDA to Add Rare Nerve Syndrome Warning to Johnson & Johnson
[ad_1] The Food and Drug Administration plans to warn that Johnson & Johnson’s coronavirus vaccine could lead to an increased risk of a rare neurological condition known as Guillain-Barré syndrome.Read More
FDA Is Investigating Its Own Alzheimer’s Drug Approval
[ad_1] The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease, which hasRead More
In A Reversal, FDA Calls for Limits on Who Takes Alzheimer’s Drugs
[ad_1] Faced with harsh criticism for approving a controversial drug for all Alzheimer’s patients, the Food and Drug Administration has largely narrowed his recommendationsuggests that only those with mild memoryRead More